Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
News
₹ 0.89
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Biogen Pharmachem Industries Ltd. engages in the business of trading in shares and securities. The company was founded on July 13, 1995 and is headquartered in Rajkot, India.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only
